← Leaderboards
Peter C. Brooks
New York University School Of Medicine
$5,696,970
Attributed
$5,696,970
Total exposure
5
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $524.3K · FY2006–21$1M$750K$500K$250K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
Funding mix
By agency
NIH$5,696,970 · 5
By mechanism
R01$5,090,324 · 2
P20$376,696 · 2
R29$229,950 · 1
Top collaborators
No co-investigators on record.
Most similar at New York University School Of Medicine
Same institution · by research overlap
- Iman Osman$8,470,073
- Leonardo Trasande$95,407,856
- Michelle Krogsgaard$10,631,626
- Sandra Demaria$8,493,423
- Annekatrin Lukanova$1,952,444
Others in their field
Top investigators on “Angiogenesis”
- David Heimbrook · Leidos Biomedical Research, Inc.$75,067,502
- Steven Terry Rosen · Beckman Research Institute/City Of Hope$59,567,306
- Martin Friedlander · Scripps Research Institute$48,350,175
- Larry Arthur$33,866,306
- Michael Simons · Yale University$30,647,106
- Henry Shelton Earp · Univ Of North Carolina Chapel Hill$29,372,588
Research focus
AngiogenesisCollagenMelanomaIntegrinsApoptosisEndothelial CellsIn VivoDesignEpitopesCell BehaviorMediatingTumorCell AdhesionChick EmbryoPlayProgramsSerumTumor GrowthBaseBlood CirculationCell PhysiologyPeptidesMigrationTumor Progression
Grant awards (21)
Role of the macrophage derived XL313 epitope in angiogenesis and tumor growth$356,850
R01 · FY2021 · CA · contact PI
Role of the macrophage derived XL313 epitope in angiogenesis and tumor growth$356,850
R01 · FY2020 · CA · contact PI
Role of the macrophage derived XL313 epitope in angiogenesis and tumor growth$346,144
R01 · FY2019 · CA · contact PI
Role of the macrophage derived XL313 epitope in angiogenesis and tumor growth$356,850
R01 · FY2018 · CA · contact PI
Role of the macrophage derived XL313 epitope in angiogenesis and tumor growth$356,850
R01 · FY2017 · CA · contact PI
Cryptic Domains of Collagen-IV in Tumor Growth$325,617
R01 · FY2011 · CA · contact PI
Cryptic Domains of Collagen-IV in Tumor Growth$335,687
R01 · FY2010 · CA · contact PI
Cryptic Domains of Collagen-IV in Tumor Growth$335,687
R01 · FY2009 · CA · contact PI
ROLE OF INSULIN-LIKE GROWTH FACTOR BINDING PROTEINS (IGFBPS) IN ANGIOGENESIS$188,035
P20 · FY2009 · RR · contact PI
Cryptic Domains of Collagen-IV in Tumor Growth$335,687
R01 · FY2008 · CA · contact PI
ROLE OF INSULIN-LIKE GROWTH FACTOR BINDING PROTEINS (IGFBPS) IN ANGIOGENESIS$188,661
P20 · FY2008 · RR · contact PI
Cryptic Domains of Collagen-IV in Tumor Growth$336,765
R01 · FY2007 · CA · contact PI
CRYPTIC DOMAINS OF COLLAGEN IV IN TUMOR GROWTH$60,840
R01 · FY2006 · CA · contact PI
CRYPTIC DOMAINS OF COLLAGEN IV IN TUMOR GROWTH$360,814
R01 · FY2004 · CA
CRYPTIC DOMAINS OF COLLAGEN IV IN TUMOR GROWTH$350,780
R01 · FY2003 · CA
CRYPTIC DOMAINS OF COLLAGEN IV IN TUMOR GROWTH$299,150
R01 · FY2002 · CA
CRYPTIC DOMAINS OF COLLAGEN IV IN TUMOR GROWTH$291,560
R01 · FY2001 · CA
PROTEOLYZED COLLAGEN IN ANGIOGENESIS AND APOPTOSIS$115,500
R29 · FY2001 · CA
CRYPTIC DOMAINS OF COLLAGEN IV IN TUMOR GROWTH$284,193
R01 · FY2000 · CA
PROTEOLYZED COLLAGEN IN ANGIOGENESIS AND APOPTOSIS$67,374
R29 · FY2000 · CA
PROTEOLYZED COLLAGEN IN ANGIOGENESIS AND APOPTOSIS$47,076
R29 · FY2000 · CA